The first indigenously developed tissue engineering scaffold from mammalian organs, an animal-derived Class D Biomedical Device that can rapidly heal skin wounds at low-cost with minimum scarring, has received approval from the Indian Drugs Controller.
The Cholederm is the first indigenously developed tissue engineering scaffold from mammalian organs.
The Cholederm is an animal-derived Class D Biomedical Device that can rapidly heal skin wounds at low-cost with minimum scarring.
An advanced wound care product developed by the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), named Cholederm, has won the approval of the Central Drugs Standard Control Organisation (CDSCO) as a Class D medical device.
Low-cost tissue-engineering scaffold Cholederm — developed by Thiruvananthapuram-based Sree Chitra Tirunal Institute for Medical Sciences & Technology — approved by DCGI.
Access to this page is restricted to healthcare professionals to ensure that medical information is provided to the appropriate audience.
The details collected are solely for professional engagement and will not be shared or used for any other purpose.